Navidea biopharmaceuticals, inc. announces special meeting of stockholders to be held july 8, 2024

Columbus, ohio--(business wire)--navidea biopharmaceuticals, inc. (otc: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will be hosting a virtual meeting of its stockholders at 1pm et on monday, july 8th, 2024. the purpose of the special meeting is to consider and vote upon (i) an amendment to the company's certificate of incorporation to allow stockholders to act by written consent, and (ii.
NAVB Ratings Summary
NAVB Quant Ranking